Shared Savings model will have to mature and refine to adapt to industry changes
The number of accountable care organizations (ACOs) has doubled during the past year with Medicare ACOs taking the lead over commercial entries into the healthcare space, according to Leavitt Partners.
Since the inauguration of the Medicare Pioneer ACO and Shared Savings programs, the model has grown to 106 total ACO players providing care for about 1.6 million beneficiaries, according to the Medicare Payment Advisory Commission (MedPAC).
Despite the growth of Medicare ACOs, Stephen Thome, senior manager, healthcare practice for Ernst & Young in Cleveland, says commercial ACOs are growing at an organic pace and are not affected by the same regulations as their Medicare counterparts-federal governance, management and leadership requirements.
“Commercial payers have come up with accommodations to share start-up costs, and the process for attributing patients to the ACO can be more transparent and timely,” he says.
He also says ACOs will need to develop a more sustainable payment model to survive long term. The initial Shared Savings model will need to mature to provide more predictable payment streams and to align incentives for payers and providers.
“They also will need to deliver on medical management, and provide better care for less,” Thome says. “Otherwise, they will become irrelevant and add another layer of costs.”
But as the competition among ACOs increases, he believes that the healthcare marketplace will see a bend in the cost curve and improved quality of care.
“Five years ago, the partnerships between plans and providers in an ACO would have been unthinkable,” he says.
Any ACO partnership would require an information technology infrastructure, says Gene Muise, director of pharmacy for Mount Auburn Cambridge Independent Practice Assn. (MACIPA), a 500-multispecialty physician group in Cambridge, Mass., and an original Pioneer ACO.
“If ACOs can meet performance measures, improve quality, save money and boost buy-in and communications with health plans, the model holds promise for the future,” Muise says.
MACIPA has experience with models similar to an ACO as far back as 1985, when it secured risk-based contracts covering individuals in HMOs offered by Tufts Health Plan, followed by Blue Cross Blue Shield of Massachusetts and Harvard Pilgrim Health Care in the mid-1990s.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
High-Dose Eylea Shows Unique Properties in nAMD and DME | AAO 2024
October 22nd 2024A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks to as long as 20 weeks for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen